fbpx
March 10, 2022

FDA Working to Lift Barriers to Generic Drug Competition

June 21, 2017 By: Scott Gottlieb, M.D. FDA Commissioner Scott Gottlieb, MD Too many patients are being priced out of the medicines they need. While FDA […]
March 10, 2022

How FDA Plans to Help Consumers Capitalize on Advances in Science

July 7, 2017 By: Scott Gottlieb, M.D. FDA Commissioner Scott Gottlieb, MD We’re at a point in science where new medical technologies hold out the promise […]
March 8, 2022

Ensuring Patient Safety and Drug Manufacturing Quality Through Partnership with European Union Regulators

Image By: Anna K. Abram, Deputy Commissioner for Policy, Legislation and International Affairs, and Mark Abdoo, Associate Commissioner for Global Policy and Strategy As drug manufacturing […]
March 8, 2022

Delivering Promising New Medicines Without Sacrificing Safety and Efficacy

Image By Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research and Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research The FDA […]
March 8, 2022

FDA’s Comprehensive Response to HIV — Part I

Image By: Ned Sharpless, M.D., Acting Commissioner Our nation has been engaged in a battle against the HIV/AIDS epidemic since the early 1980’s. Over the past 37 […]
March 8, 2022

FDA’s Comprehensive Response to HIV — Part II

Image By: Ned Sharpless, M.D., Acting Commissioner Ned Sharpless, M.D. As I discussed in the first part of this Voices article, the FDA is engaged on many […]
March 8, 2022

The FDA’s Critical Focus on Women’s Health

Image By: Amy Abernethy, M.D., Principal Deputy Commissioner, Kaveeta Vasisht, M.D., Pharm.D., Acting Associate Commissioner for Women’s Health, Office of Women’s Health, and, CAPT Terri L. […]
March 8, 2022

To Help Reduce Drug Shortages, We Need Manufacturers to Sell Quality — Not Just Medicine

Image By: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research You might not always shop based solely on the lowest price. For instance, if […]
March 8, 2022

Patient Perspective Is Vital to FDA’s Work

[embedded content] By Amy Abernethy, M.D., Ph.D., Principal Deputy Commissioner and Acting Chief Information Officer As an oncologist, I was eager to come work at the […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0